Taking drops of a medical dye is trending in wellness and biohacking circles. Some influencers claim it boosts longevity and ...

Methylene blue is suddenly everywhere in wellness circles, praised as a brain booster, longevity aid, and even a cellular ...

Methylene blue (ProvayBlue) is a medication doctors use to treat a rare blood condition called methemoglobinemia. Naturally, methylene blue is a solid. But as a medical treatment, it’s dissolved in ...

This vibrantly colored chemical was originally created for use as a fabric dye. Kittisak Kaewchalun via iStock/Getty Images Plus The internet is abuzz with tributes to a liquid chemical called ...

A new social media trend is making headlines: Methylene blue is being touted as a cognitive booster and antiaging miracle. Influencers such as Ben Greenfield are promoting the use of this chemical to ...

Methylene blue treats methemoglobinemia, a blood condition. Recently, methylene blue supplements have gained attention for their alleged cognitive and aging support benefits, but these uses require ...

Wellness influencers and biohackers claim methylene blue can amp up cognition, memory, and mood. Learn what scientists know about this compound recently linked to RFK Jr. A video showing Robert F.

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A viral video that appears to show Robert F. Kennedy Jr ...

Malaria continues to place a substantial burden on many emerging economies, contributing to significant loss of life, ...

Methylene blue is both a dye and an FDA-approved medication. Described as the first fully synthetic drug used in medicine, methylene blue was initially synthesized by a German chemist in 1876, and 15 ...

The internet is abuzz with tributes to a liquid chemical called methylene blue that is being sold as a health supplement. Over the past five or 10 years, methylene blue has come to be touted online as ...

Lorne J. Hofseth does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...